H. pylori/NSAID - Negative peptic ulcer - The mucin theory

Medical Hypotheses

Volumn 75, Issue 5, 2010, Pages 433-435

  Niv, Yaron ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; MUCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PEPSIN A; PROSTAGLANDIN SYNTHASE;

ARTICLE; CLINICAL TRIAL; DRUG EFFECT; ENZYME INHIBITION; EPIGENETICS; HELICOBACTER PYLORI; HUMAN; IDIOPATHIC DISEASE; INFECTION RATE; MULTICENTER STUDY; NONHUMAN; PEPTIC ULCER; PH; PROTEIN FUNCTION; PROTEIN SECRETION; STOMACH MUCOSA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HELICOBACTER PYLORI; HUMANS; MUCINS; PEPTIC ULCER;

HELICOBACTER PYLORI;

EID: 77957017170     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.04.015     Document Type: Article

References (25)

1. Malfertheiner P., Chan F.K.L., McColl K.E.L. Peptic ulcer disease. Lancet 2009, 374:1449-1461.
2. Mc Coll K.E. How I manage H. pylori-negative, NSAID/aspirin-negative peptic ulcers. Am J Gastroenterol 2009, 104:190-193.
3. Jyotheeswaran S., Shah A.N., Jin H.O., et al. Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?. Am J Gastroenterol 1998, 93:574-578.
4. Yakoob J., Jafri W., Jafri N., et al. Prevalence of non-Helicobacter pylori duodenal ulcer in Karachi, Pakistan. World J Gastroenterol 2005, 11:3562-3565.
5. Ciociola A.A., McSorley D.J., Turner K., et al. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol 1999, 94:1834-1840.
6. Xia H.H.X., Wong B.C.Y., Wong K.W., et al. Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: a long-term prospective study. Aliment Pharmacol Ther 2001, 15:1875-1882.
7. Chan H.L., Wu J.C., Chan F.K., et al. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients. Gastrointest Endosc 2001, 53:438-442.
8. Arroyo M.T., Forne M., de Argila C.M., et al. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in Southern Europe. Helicobacter 2004, 9:249-254.
9. Nishikawa K., Sugiyama T., Kato M., et al. Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. Eur J Gastroenterol Hepatol 2000, 12:635-640.
10. Gisbert J.P., Blanco M., Mateos J.M., et al. H. pylori-negative duodenal ulcer prevalence and causes in 774 patients. Dig Dis Sci 1999, 44:2295-2302.
11. Jensen P.H., Kolarich D., Packer N.H. Mucin-type O-glycosylation - putting the pieces together. FEBS J 2010, 277:81-94.
12. Phillipson M., Johansson M.E., Henriksnäs J., et al. The gastric mucus layers: constituents and regulation of accumulation. Am J Physiol Gastrointest Liver Physiol 2008, 295:G806-G812.
13. Morgenstern S., Koren R., Fraser G., et al. Gastric corpus mucin expression after partial gastrectomy, in relation to colonization with Helicobacter pylori. J Clin Gastroenterol 2001, 32:218-221.
14. Morgenstern S., Koren R., Moss S.F., et al. Does Helicobacter pylori affect gastric mucin expression? Relationship between gastric antral mucin expression and H. pylori colonization. Eur J Gastroenterol Hepatol 2001, 13:19-23.
15. Ho S.B., Takamura K., Anway R., et al. The adherent gastric mucous layer is composed of alternating layers of MUC5AC and MUC6 mucin proteins. Dig Dis Sci 2004, 49:1598-1606.
16. Tanaka S., Mizuno M., Maga T., et al. H. pylori decreases gastric mucin synthesis via inhibition of galactosyltransferase. Hepatogastroenterology 2003, 50:1739-1742.
17. Kawakubo M., Ito Y., Okimura Y., et al. Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science 2004, 305:1003-1006.
18. Celli J.P., Turner B.S., Afdhal N.H., et al. Helicobacter pylori moves through mucus by reducing mucin viscoelasticity. PNAS 2009, 106:14321-14326.
19. Kobayashi M., Lee H., Nakayama J., et al. Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection. Glycobiology 2009, 19:453-461.
20. Andrianifahanana M., Moniaux N., Batra S.K. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochem Biophys Acta 2006, 1765:189-222.
21. Rousseau K., Byrne C., Griesinger G., et al. Allelic association and recombination hotspots in the mucin gene (MUC) complex on chromosome 11p15.5. Ann Hum Genet 2007, 71:561-569.
22. Vincent A., Perrais M., Desseyn J.L., et al. Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. Oncogene 2007, 26:6566-6576.
23. Fujisawa T., Velichko S., Thai P., et al. Regulation of airway MUC5AC expression by IL-1β and IL-17A; the NF-B paradigm. J Immunol 2009, 183:6236-6243.
24. Wong G.L., Wong V.W., Chan Y., et al. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology 2009, 137:525-531.
25. Gisbert J.P., Calvet X. Review article: Helicobacter pylori-negative duodenal ulcer disease. Aliment Pharmacol Ther 2009, 30:791-815.